Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO BSE: 500660

₹2594.40

(-2.78%)

Sat, 14 Feb 2026, 07:00 pm

MTF 5xInvest in Glaxosmithkline Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap439.42B

PE Ratio43.05

Dividend1.62

Health Technology

Pharmaceuticals: Major

24.5K

Glaxosmithkline Pharmaceuticals Income Statement

Income Statement Balance Sheet Cashflow

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	15.04B	15.82B	15.97B	16.85B	19.08B	22.02B	24.28B	26.77B	25.49B	26.29B	27.46B	29.08B	28.71B	31.28B	32.24B	29.26B	32.78B	32.52B	34.53B	37.49B
Gross profit	4.80B	5.59B	6.12B	6.29B	7.11B	10.61B	11.13B	11.69B	9.42B	9.27B	9.03B	8.68B	9.34B	10.41B	10.64B	8.37B	10.96B	11.78B	12.81B	15.68B
Operating expenses (excl. COGS)	-597.94M	-890.91M	-762.38M	-578.37M	-474.18M	-3.00B	-3.27B	-3.75B	-4.37B	-4.54B	-4.26B	-4.63B	-4.47B	-4.74B	-4.66B	-3.11B	-3.91B	-4.23B	-4.36B	-4.45B
Selling/general/admin expenses, total	—	—	—	—	—	-2.33B	-2.60B	-2.83B	-3.15B	-3.11B	-3.97B	-4.34B	-4.12B	-4.66B	-4.36B	-2.73B	-3.64B	-3.59B	-3.87B	-3.92B
Research & development	—	-42.98M	-44.02M	-46.37M	-46.68M	-44.34M	-38.28M	-24.03M	-26.29M	—	-19.96M	-18.96M	-22.52M	-23.27M	-21.80M	-18.07M	-18.29M	-19.10M	-25.44M	-26.12M
Selling/general/admin expenses, other	—	—	—	—	—	-2.29B	-2.56B	-2.80B	-3.12B	-3.11B	-3.95B	-4.32B	-4.09B	-4.64B	-4.34B	-2.71B	-3.62B	-3.57B	-3.85B	-3.89B
Other operating expenses, total	-597.94M	-890.91M	-762.38M	-578.37M	-474.18M	-672.55M	-673.98M	-920.73M	-1.22B	-1.44B	-292.89M	-287.53M	-350.45M	-78.64M	-299.60M	-378.89M	-276.62M	-639.72M	-483.84M	-525.71M
Operating income	4.20B	4.70B	5.31B	5.67B	6.59B	7.57B	7.83B	7.94B	5.04B	4.73B	4.77B	4.05B	4.88B	5.67B	5.98B	5.27B	7.04B	7.55B	8.46B	11.23B
Non-operating income, total	602.21M	895.56M	896.06M	1.27B	1.01B	1.15B	1.51B	403.36M	2.07B	1.22B	1.02B	1.06B	524.65M	1.16B	-2.92B	-728.44M	748.15M	813.56M	-295.62M	1.37B
Interest expense, net of interest capitalized	-16.72M	-6.37M	-6.37M	-257.00K	-85.00K	0	0	0	0	0	-1.85M	-183.00K	-408.00K	-3.32M	-38.98M	-31.82M	-17.37M	-13.98M	-15.75M	-11.79M
Interest capitalized	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-operating income, excl. interest expenses	618.93M	901.93M	902.43M	1.27B	1.01B	1.15B	1.51B	1.89B	2.02B	1.73B	1.16B	1.09B	522.90M	1.13B	6.00B	1.05B	963.75M	933.66M	1.35B	1.38B
Non-operating interest income	268.60M	361.69M	470.92M	732.60M	598.49M	1.00B	1.45B	1.75B	1.74B	1.59B	1.21B	721.09M	525.93M	772.79M	659.99M	392.90M	449.10M	698.12M	678.50M	713.79M
Miscellaneous non-operating expense	350.32M	540.24M	431.51M	538.42M	408.74M	143.63M	59.83M	139.09M	276.94M	146.12M	-54.53M	367.35M	-3.04M	355.35M	5.34B	654.86M	514.66M	235.54M	674.65M	667.46M
Unusual income/expense	—	—	—	—	—	—	—	-1.48B	49.77M	-518.81M	-136.85M	-24.38M	2.16M	30.62M	-8.88B	-1.74B	-198.24M	-106.12M	-1.63B	0
Pretax income	4.81B	5.60B	6.21B	6.94B	7.59B	8.72B	9.34B	8.34B	7.11B	5.94B	5.78B	5.11B	5.40B	6.83B	3.06B	4.54B	7.79B	8.36B	8.16B	12.60B
Taxes	-1.69B	-1.92B	-2.11B	-2.31B	-2.59B	-2.93B	-3.05B	-2.72B	-2.30B	-2.23B	-2.02B	-1.74B	-1.89B	-2.37B	-2.13B	-1.67B	-3.98B	-2.29B	-2.26B	-3.32B
Non-controlling/minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	3.12B	3.67B	4.10B	4.63B	5.00B	5.78B	6.29B	5.62B	4.82B	3.71B	3.76B	3.37B	3.51B	4.45B	932.05M	2.87B	3.81B	6.08B	5.90B	9.28B
Net income	3.12B	3.67B	4.10B	4.63B	5.00B	5.78B	6.29B	5.62B	4.82B	3.71B	3.76B	3.37B	3.51B	4.45B	932.05M	3.58B	16.95B	6.11B	5.90B	9.28B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	3.12B	3.67B	4.10B	4.63B	5.00B	5.78B	6.29B	5.62B	4.82B	3.71B	3.76B	3.37B	3.51B	4.45B	932.05M	3.58B	16.95B	6.11B	5.90B	9.28B
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	4.40B	4.90B	5.52B	5.83B	6.75B	7.79B	8.06B	8.12B	5.24B	4.93B	5.01B	4.31B	5.25B	6.16B	6.81B	6.05B	7.72B	8.21B	9.15B	11.90B
EBIT	4.20B	4.70B	5.31B	5.67B	6.59B	7.61B	7.86B	7.94B	5.04B	4.73B	4.77B	4.05B	4.88B	5.67B	5.98B	5.27B	7.04B	7.55B	8.46B	11.23B
Total operating expenses	-10.83B	-11.12B	-10.66B	-11.18B	-12.49B	-14.45B	-16.45B	-18.83B	-20.45B	-21.56B	-22.69B	-25.04B	-23.84B	-25.61B	-26.26B	-23.99B	-25.74B	-24.97B	-26.07B	-26.26B
Prepaid expenses	139.93M	13.37B	515.38M	18.36B	13.75M	13.75M	25.05B	12.37M	17.50M	2.62B	277.25M	258.04M	117.89M	111.30M	117.89M	146.49M	139.26M	149.60M	206.18M	188.86M
Deferred income, current	—	—	—	—	—	—	—	—	—	—	—	—	33.29M	5.57B	37.95M	49.10M	43.47M	70.78M	75.50M	66.08M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	202.50M	76.23M	76.23M	34.55M	64.69M	24.92M
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	114.46M	106.10M	98.16M	91.08M	75.87M	87.40M	59.59M	32.13M	47.89M	101.16M	107.88M	—	—	241.18M	172.38M	155.71M	188.86M	181.96M	171.36M	153.52M
Deferred income, non-current	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	-2.09B	-2.36B	-2.61B	-3.03B	-3.37B	-2.53B	-3.38B	-3.78B	-4.21B	-4.94B	-6.37B	-5.10B	-3.06B	-3.57B	-4.08B	-6.77B	-5.07B	-15.25B	-5.42B	-7.49B
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800